Switch theme
Sign up to access all valuation multiples
Ramsay Health Care is one of the largest private healthcare providers in the world, with over 460 facilities across 10 countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK where it ranks fifth. Ramsay Sante, which operates the European regions other than the UK, is a 52.5%-owned subsidiary of Ramsay Health Care. The company typically earns about 60% of consolidated earnings in Australia and 30% in France. Ramsay Health Care undertakes both private and publicly funded healthcare.
1975
93.5K+
LTM Revenue $11.3B
LTM EBITDA $1.4B
$12.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ramsay Health has a last 12-month revenue (LTM) of $11.3B and a last 12-month EBITDA of $1.4B.
In the most recent fiscal year, Ramsay Health achieved revenue of $10.6B and an EBITDA of $1.2B.
Ramsay Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ramsay Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $11.3B | XXX | $10.6B | XXX | XXX | XXX |
| Gross Profit | $8.8B | XXX | $8.3B | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 78% | XXX | XXX | XXX |
| EBITDA | $1.4B | XXX | $1.2B | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $659M | XXX | $535M | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $188M | XXX | $571M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $2.8B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ramsay Health's stock price is AUD 38 (or $25).
Ramsay Health has current market cap of AUD 8.8B (or $5.7B), and EV of AUD 20.0B (or $12.9B).
See Ramsay Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12.9B | $5.7B | XXX | XXX | XXX | XXX | $0.80 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ramsay Health has market cap of $5.7B and EV of $12.9B.
Ramsay Health's trades at 1.2x EV/Revenue multiple, and 10.0x EV/EBITDA.
Equity research analysts estimate Ramsay Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ramsay Health has a P/E ratio of 30.1x.
See valuation multiples for Ramsay Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5.7B | XXX | $5.7B | XXX | XXX | XXX |
| EV (current) | $12.9B | XXX | $12.9B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 9.2x | XXX | 10.0x | XXX | XXX | XXX |
| EV/EBIT | 19.5x | XXX | 21.5x | XXX | XXX | XXX |
| EV/Gross Profit | 1.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 30.1x | XXX | 14.9x | XXX | XXX | XXX |
| EV/FCF | 35.2x | XXX | 36.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialRamsay Health's last 12 month revenue growth is 5%
Ramsay Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Ramsay Health's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ramsay Health's rule of X is 24% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ramsay Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | 16% | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 73% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ramsay Health acquired XXX companies to date.
Last acquisition by Ramsay Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Ramsay Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ramsay Health founded? | Ramsay Health was founded in 1975. |
| Where is Ramsay Health headquartered? | Ramsay Health is headquartered in Australia. |
| How many employees does Ramsay Health have? | As of today, Ramsay Health has 93.5K+ employees. |
| Who is the CEO of Ramsay Health? | Ramsay Health's CEO is Mr. Craig Mcnally. |
| Is Ramsay Health publicy listed? | Yes, Ramsay Health is a public company listed on ASX. |
| What is the stock symbol of Ramsay Health? | Ramsay Health trades under RHC ticker. |
| When did Ramsay Health go public? | Ramsay Health went public in 1997. |
| Who are competitors of Ramsay Health? | Similar companies to Ramsay Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Athens Medical Centre. |
| What is the current market cap of Ramsay Health? | Ramsay Health's current market cap is $5.7B |
| What is the current revenue of Ramsay Health? | Ramsay Health's last 12 months revenue is $11.3B. |
| What is the current revenue growth of Ramsay Health? | Ramsay Health revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Ramsay Health? | Current revenue multiple of Ramsay Health is 1.1x. |
| Is Ramsay Health profitable? | Yes, Ramsay Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ramsay Health? | Ramsay Health's last 12 months EBITDA is $1.4B. |
| What is Ramsay Health's EBITDA margin? | Ramsay Health's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Ramsay Health? | Current EBITDA multiple of Ramsay Health is 9.2x. |
| What is the current FCF of Ramsay Health? | Ramsay Health's last 12 months FCF is $365M. |
| What is Ramsay Health's FCF margin? | Ramsay Health's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Ramsay Health? | Current FCF multiple of Ramsay Health is 35.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
